Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension is a research paper published in CHEST Journal (2021). On theSindex it has a DataRank of 0.596. It has been cited 52 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.596
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01 HL159886-01
National Institutes of Health
Grant: R01 HL134776
National Institutes of Health
Grant: R01 HL139664
NHLBI NIH HHS
Grant: R21 HL156761
NHLBI NIH HHS
Grant: R01 HL159886
NHLBI NIH HHS
Grant: R25 HL147666
Fields of Study
MeSH Terms
Keywords
Additional file 2 of Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study
Additional file 2 of Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study
Additional file 3 of Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study
Additional file 3 of Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study
Additional file 1 of Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study
Additional file 1 of Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study